Innovent Biologics, Inc. (HKG:1801)

Hong Kong · Delayed Price · Currency is HKD

82.05

-7.05 (-7.91%)

Oct 22, 2026, 2:05 PM HKT

Innovent Biologics Analyst Ratings

Ratings History

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst UBS No rating	UBS	Buy Maintains $135.30	Buy	Maintains	$135.30	+64.90%	Oct 19, 2026
Jill Wu CMB International Securities	CMB International Securities	Buy Maintains $130.25 → $138.63	Buy	Maintains	$130.25 → $138.63	+68.96%	Oct 16, 2026
Unknown Analyst Bernstein No rating	Bernstein	Buy Maintains $128.00	Buy	Maintains	$128.00	+56.00%	Sep 22, 2026
Unknown Analyst Citic Securities No rating	Citic Securities	Buy Maintains $125.00	Buy	Maintains	$125.00	+52.35%	Sep 17, 2026
Mark Kong CFA DBS	DBS	Buy Reiterates $144.00	Buy	Reiterates	$144.00	+75.50%	Sep 14, 2026
Unknown Analyst Huatai Securities No rating	Huatai Securities	Buy Maintains $129.54	Buy	Maintains	$129.54	+57.88%	Sep 13, 2026
Unknown Analyst BOCOM International Holdings Company No rating	BOCOM International Holdings Company	Buy Maintains $118.00 → $129.00	Buy	Maintains	$118.00 → $129.00	+57.22%	Sep 3, 2026
Yang Huang J.P. Morgan	J.P. Morgan	Buy Maintains $117.00 → $140.00	Buy	Maintains	$117.00 → $140.00	+70.63%	Aug 28, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

Investment ideas from the top Wall Street analysts
Unlimited access to all data and tools
Advanced analyst filtering and sorting options
Up to 3 years of analyst rating history

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate: The percentage of ratings that are profitable.
Average Return: The average percentage return within one year of the rating.
Rating Count: The more ratings the analyst has provided, the higher the score.
Recency: Ratings provided within the past year contribute to a higher score.